Skip to content

Antagonistic interaction between caffeine and ketamine in zebrafish: Implications for aquatic toxicity.

Zhenglu Wang, Jindong Xu, Wei Du

Environmental science and ecotechnology September 1, 2024 DOI: 10.1016/j.ese.2024.100437 via PubMed

Summary

AI-generated from the abstract

Caffeine and ketamine, both found in surface waters across Asia, interact in a way that reduces caffeine's harmful effects on zebrafish larvae. Ketamine at concentrations of 10-250 ng L-1 counteracts the hyperactivity and disrupted daily rhythms caused by 2 mg L-1 of caffeine, with the effect depending on dose. Developmental abnormalities in larvae exposed to caffeine drop from 26.7% to 6.7% when ketamine is present. The two chemicals compete for binding sites on the GABA-A receptor, explaining their antagonistic relationship. After seven days of recovery, caffeine's adverse effects persist, while those in the caffeine-plus-ketamine groups lessen, especially at 10 ng L-1 of ketamine. The findings highlight the need to assess risks of co-pollution and suggest that nighttime fish behavior may serve as a sensitive toxicity biomarker.

Study at a glance

Characteristics Experimental study Pilot study Peer reviewed
Population Zebrafish larvae
Interventions Caffeine Ketamine
Dose 2 mg L-1 of CF; 10-250 ng L-1 of KET
Duration Seven-day recovery period
Topics Ketamine
Keywords Antagonistic effect Caffeine Gabaergic synapse Systems toxicology
Citations 6
Key finding Ketamine antagonizes the adverse effects of caffeine on zebrafish larvae by modulating the GABAergic synapse pathway, reducing hyperactivity, circadian rhythm disruption, and developmental abnormalities.

Abstract

The coexistence of caffeine (CF) and ketamine (KET) in surface waters across Asia has been widely reported. Previous studies have implied that CF and KET may share a mechanism of action. However, the combined toxicity of these two chemicals on aquatic organisms remains unclear at environmental levels, and the underlying mechanisms are not well understood. Here we demonstrate that KET antagonizes the adverse effects of CF on zebrafish larvae by modulating the gamma-aminobutyric acid (GABA)ergic synapse pathway. Specifically, KET (10-250 ng L-1) ameliorates the locomotor hyperactivity and impaired circadian rhythms in zebrafish larvae induced by 2 mg L-1 of CF, showing a dose-dependent relationship. Additionally, the developmental abnormalities in zebrafish larvae exposed to CF are mitigated by KET, with an incidence rate reduced from 26.7% to 6.7%. The competition between CF and KET for binding sites on the GABA-A receptor (in situ and in silico) elucidates the antagonistic interactions between the two chemicals. Following a seven-day recovery period, the adverse outcomes of CF exposure persist in the fish, whereas the changes observed in the CF + KET groups are significantly alleviated, especially with KET at 10 ng L-1. Based on these results, it is imperative to further assess the environmental risks associated with CF and KET co-pollution. This pilot study underscores the utility of systems toxicology approaches in estimating the combined toxicity of environmental chemicals on aquatic organisms. Moreover, the nighttime behavioral functions of fish could serve as a sensitive biomarker for evaluating the toxicity of psychoactive substances.

Explore topics

Comments

No comments yet.

Log in to comment